U.S. Physical Therapy
USPH

U.S. Physical Therapy (USPH) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Barrington ResearchMaintainedOutperform$98.00 from $90.00Aug 10, 2026
CitizensMaintainedMarket Outperform$98.00Jun 24, 2026
Barrington ResearchMaintainedOutperform$90.00 from $103.00May 13, 2026
CitizensMaintainedMarket Outperform$98.00 from $113.00May 8, 2026
JefferiesInitiated CoverageBuy$102.00Mar 10, 2026
Barrington ResearchMaintainedOutperform$103.00Feb 20, 2026
Barrington ResearchMaintainedOutperform$103.00Jan 5, 2026
JP MorganMaintainedOverweight$100.00 from $110.00Nov 24, 2025
Barrington ResearchMaintainedOutperform$103.00Oct 24, 2025
JP MorganInitiated CoverageOverweight$110.00Sep 18, 2025
Barrington ResearchMaintainedOutperform$103.00 from $98.00Aug 8, 2025
Barrington ResearchMaintainedOutperform$98.00Jul 1, 2025
JMP SecuritiesMaintainedMarket Outperform$113.00Apr 22, 2025
JP MorganMaintainedOverweight$110.00 from $120.00Mar 19, 2025
Barrington ResearchMaintainedOutperform$98.00 from $108.00Feb 28, 2025
B of A SecuritiesUpgradedNeutral → Buy$115.00 from $100.00Dec 16, 2024
JMP SecuritiesInitiated CoverageMarket Outperform$113.00Dec 16, 2024
JP MorganMaintainedOverweight$120.00 from $117.00Dec 3, 2024
Barrington ResearchMaintainedOutperform$108.00Nov 21, 2024
Barrington ResearchMaintainedOutperform$108.00Nov 7, 2024

Frequently asked questions

  • What is the latest analyst rating on USPH?

    On Aug 10, 2026, Barrington Research maintained U.S. Physical Therapy at Outperform with a price target of $98.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.